Neurocrine Biosciences NBIX
NASDAQ NBIX
$174.41 +5.27 (+3.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Neurocrine Biosciences (NBIX) Shares Repurchased (2024 - 2026)

Updated

Neurocrine Biosciences' Shares Repurchased came in at $92.1 million for Q3 2026, up 667.5% from the prior quarter.

Analysis

Neurocrine Biosciences (NBIX) Shares Repurchased (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Neurocrine Biosciences reported Shares Repurchased of $158.1 million, down 66.2% year-over-year; for FY2025, it was $167.7 million, down 44.1% from FY2024.

  • Going back by year, Shares Repurchased was $300 million in FY2024.
  • The Q3 2026 figure represents the highest quarterly Shares Repurchased since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 370.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Neurocrine Biosciences 17.13 Bn 13.21 Bn 1.10 Bn 92.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 92.10 Mn
Jun 30, 2026 12.00 Mn
Mar 31, 2026 54.00 Mn
Jun 30, 2025 17.70 Mn
Mar 31, 2025 150.00 Mn
Dec 31, 2024 300.00 Mn
API Access

Neurocrine Biosciences Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=NBIX&period=max&api_key=YOUR_API_KEY